FDA
approval
· 2023-11-20
FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Glenmark Therapeutics Inc., USA)
Summary
FDA approved Glenmark Therapeutics’ supplemental application for Citalopram Hydrobromide as a generic antidepressant. Citalopram hydrobromide is used to treat m…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CITALOPRAM HYDROBROMIDE (CITALOPRAM HYDROBROMIDE)